Last reviewed · How we verify
NCT06273267: StartSPP
Initiating Pediatric Palliative Care in ACT Group 4
trial testing Collection of data from the patient's medical file in Encephalopathy in 126 participants. Completed in 22 July 2024.
22 July 2024
Quick facts
| Lead sponsor | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 126 |
| Start date | 22 December 2023 |
| Primary completion | 22 July 2024 |
| Estimated completion | 22 July 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Collection of data from the patient's medical file
Conditions studied
- Encephalopathy — all drugs for Encephalopathy →
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Cerebral Malformation — all drugs for Cerebral Malformation →
- Traumatic Head Injury — all drugs for Traumatic Head Injury →
Sponsor
Assistance Publique - Hôpitaux de Paris — full company profile →
Who can join
Under 25, any sex, with Encephalopathy or Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Due to the wide range of diagnoses encountered in pediatric palliative care, the Association for Children's Palliative Care (ACT) and the Royal College of Paediatrics and Child Health (RCPCH) have developed a classification of life-limiting illnesses, based on support models. This classification includes four groups. ACT 4 category is made up of children with a serious incurable non-progressive neurological disease (for example: anoxic ischemia, cerebral palsy, traumatic or infectious brain injuries). Although data relating to specific ACT groups are scarce, experience from clinical practice suggests that the needs and use of Pediatric palliative care resources are different across the four categories. The specific history of ACT-4 patients suggests that pediatric palliative care may be required early on in the history of the disease but effective intervention varies greatly from one patient to another. Tthis study aims to better understand the optimal timing for introducing a PPC team into the care pathway for these children. The study also aims to describe the care trajectory over the first year of PPC intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06273267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Collection of data from the patient's medical file
Trials testing the same drug.
- NCT06683937 — Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, N · not yet recruiting
- NCT06650111 — Epidemiology, Diagnosis, Medical Care and Prognosis of Tubulointerstitial Nephritis: Results of a Multicenter Retrospect · completed
- NCT06365268 — Perinatal Thoraco-abdomino-pelvic Tumors Study · completed
- NCT06517277 — Haemophilus Influenzae Pneumonia in Adults · completed
- NCT06297122 — Severe Group A Streptococcus Infections in Paris, France, 2018-2023 · completed
Other recruiting trials for Encephalopathy
Currently open trials in the same condition.
- NCT07222280 — Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy · NA · recruiting
- NCT06172491 — Automating Delirium Severity in the ICU · recruiting
- NCT05395195 — Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial) · Phase 3 · recruiting
- NCT06958341 — Neuroimmunology Registry and Biobank · recruiting
- NCT04767945 — Cirrhosis Registry of Hospitalized Patients · recruiting
Other Assistance Publique - Hôpitaux de Paris trials
Trials by the same sponsor.
- NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
- NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
- NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
- NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
- NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06273267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
- Last refreshed: 12 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06273267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing